References
- Vainio H, Morgan G. Cyclo-oxygenase 2 and breast cancer prevention. Non-steroidal anti-inflammatory agents are worth testing in breast cancer. Br Med J 1998;317:828
- Takahashi Y, Kawahara F, Noguchi M, Miwa K, Sato H, Seiki M et al. Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2. FEBS Lett 1999;460:145–8
- Prescott SM, Fitzpatrick FA. Cyclooxygenase-2 and carcino-genesis. [Review] [96 refs]. Biochim Biophys Acta 2000;1470:M69–M78
- Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998;90:455–60
- Rolland PH, Martin PM, Jacquemier J, Rolland AM, Toga M. Prostaglandin in human breast cancer: evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells. J Natl Cancer Inst 1980;64:1061–70
- Karmali RA, Welt S, Thaler HT, Lefevre F. Prostaglandins in breast cancer: relationship to disease stage and hormone status. Br J Cancer 1983;48:689–96
- Schrey MP, Patel KV. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibro-blasts. Regulation by inflammatory mediators. Br J Cancer 1995;72:1412–19
- Liu XH, Rose DP. Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines. Cancer Res 1996;56:5125–7
- Harris RE, Robertson FM, Abou-Issa HM, Farrar WB, Brueggemeier R. Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer. Med Hypotheses 1999;52: 291–2
- Gilhooly EM, Rose DP. The association between a mutated ras gene and cyclooxygenase-2 expression in human breast cancer cell lines. Int J Oncol 1999;15:267–70
- Rochlitz CF, Scott GK, Dodson JM, Liu E, Dollbaum C, Smith HS et al. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Cancer Res 1989;49:357–60
- Brueggemeier RW, Quinn AL, Parrett ML, Joarder FS, Harris RE, Robertson FM. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett 1999;140:27–35
- Parrett ML, Harris RE, Joarder FS, Ross M, Clausen K, Robertson FM. Cyclooxygenase-2 gene expression in human breast cancer. Int J Oncol 1997;10:503–7
- Harris RE, Kasbari S, Farrar WB. Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 1999;6:71–3
- Maekawa M, Sugano K, Sano H, Miyazaki S, Ushiama M, Fujita S et al. Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyper-plastic polyps. Japan J Clin Oncol 1998;28:421–6
- Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. [Review] [90 refs]. Oncologist 2000;5(Suppl):44
- Vidal H, Auboeuf D, DeVos P, Staels B, Riou J, Auwerx J et al. Quantitation of leptin mRNA in human adipose tissue by RT-competitive PCR. Qiagen News 1997;2
- Bustin SA, Gyselman VG, Williams NS, Dorudi S. Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients. Br J Cancer 1999;79:1813–20
- Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. [see comments]. J Clin Invest 2000;105: 1589–94
- Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. [erratum appears in Cell 1998 Jul 24;94:following 271] Cell 1998;93: 705–16
- Sawaoka H, Tsuji S, Tsujii M, Gunawan ES, Sasaki Y, Kawano S et al. Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 1999;79:1469–77